World's first Total-Body PET scanner gets new Cancer-Tracking tests
NCT ID NCT05160480
Summary
This study aims to improve how doctors use a special total-body PET scanner to see cancer more clearly. Researchers will test three different FDA-approved imaging agents in people with prostate cancer, breast cancer, or neuroendocrine tumors. The goal is to collect better data on how these agents work in the new scanner to potentially improve future cancer detection and monitoring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis EXPLORER Molecular Imaging Center
Sacramento, California, 95816, United States
Conditions
Explore the condition pages connected to this study.